A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus
Tags
Data and Resources
To access the resources you must log in
This item has no data
Item URL
http://data.d4science.org/ctlg/RISIS2OpenData/dedup_wf_001--56c96f5a96bb60377d2682e707d2459f |
|
Identity
Access Modality
Field | Value |
---|---|
Access Right | not available |
Attribution
Field | Value |
---|---|
Author | Gantz, Ira |
Author | Menghui Chen |
Author | Shailaja Suryawanshi |
Author | Ntabadde, Catherine |
Author | Sukrut Shah |
Author | O’Neill, Edward |
Author | Engel, Samuel |
Author | Kaufman, Keith |
Author | Eseng Lai |
Publishing
Field | Value |
---|---|
Collected From | Datacite |
Hosted By | figshare |
Publication Date | 2017-09-12 |
Publisher | Figshare |
Additional Info
Field | Value |
---|---|
Language | Undetermined |
Resource Type | Dataset |
keyword | FOS: Chemical sciences |
keyword | FOS: Health sciences |
keyword | FOS: Biological sciences |
keyword | FOS: Clinical medicine |
system:type | dataset |
Management Info
Field | Value |
---|---|
Source | https://science-innovation-policy.openaire.eu/search/dataset?datasetId=dedup_wf_001::56c96f5a96bb60377d2682e707d2459f |
Author | jsonws_user |
Last Updated | 13 January 2021, 16:29 (CET) |
Created | 13 January 2021, 16:29 (CET) |